West Pharmaceutical Services (WST) Stock Forecast & Price Target

$328.33 -2.01 (-0.61%)

Closing price 06/12/2026 03:59 PM Eastern

Extended Trading

$328.90 +0.57 (+0.17%)

As of 06/12/2026 04:58 PM Eastern

Compare

West Pharmaceutical Services - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Buy

Based on 14 Analyst Ratings

Sell
0

Hold
2

Buy
12

Based on 14 Wall Street analysts who have issued ratings for West Pharmaceutical Services in the last 12 months, the stock has a consensus rating of "Buy." Out of the 14 analysts, 2 have given a hold rating, 10 have given a buy rating, and 2 have given a strong buy rating for WST.

Consensus Price Target

$340.09
3.58% Upside

According to the 14 analysts' twelve-month price targets for West Pharmaceutical Services, the average price target is $340.09. The highest price target for WST is $400.00, while the lowest price target for WST is $295.00. The average price target represents a forecasted upside of 3.58% from the current price of $328.33.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for WST and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for West Pharmaceutical Services and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WST Analyst Ratings Over Time

Type	Current Forecast 6/13/25 to 6/13/26	1 Month Ago 5/14/25 to 5/14/26	3 Months Ago 3/15/25 to 3/15/26	1 Year Ago 6/13/24 to 6/13/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	10 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$340.09	$322.89	$314.56	$332.50
Forecasted Upside	3.58% Upside	7.58% Upside	33.48% Upside	49.93% Upside
Consensus Rating	Buy	Moderate Buy	Buy	Buy

WST Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WST Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

West Pharmaceutical Services Stock vs. The Competition

Type	West Pharmaceutical Services	Medical Companies	Broader Market
Consensus Rating Score	3.00	2.29	2.52
Consensus Rating	Buy	Hold	Moderate Buy
Predicted Upside	3.58% Upside	694.94% Upside	13.96% Upside
News Sentiment Rating	Positive News See Recent WST News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/9/2026	Barclays 3 of 5 stars	Luke Sergott 4 of 5 stars	Upgrade	Equal Weight ➝ Overweight	$310.00 ➝ $400.00	+25.01%
6/2/2026	Stephens 2 of 5 stars	Steven Etoch Not Rated	Reiterated Rating	Overweight	$360.00	+13.97%
6/1/2026	Wolfe Research 3 of 5 stars	Mike Polark Not Rated	Initiated Coverage	Outperform	$375.00	+18.72%
5/29/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kallum Titchmarsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$315.00 ➝ $325.00	+1.51%
5/13/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
4/27/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C-) ➝ Hold (C)
4/24/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
4/24/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
2/13/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Sourbeer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$340.00	+37.98%
2/13/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Bowers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$315.00	+29.70%
Get the Latest News and Ratings for WST and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.
2/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$295.00	+17.85%
10/29/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy
10/24/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Knight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$325.00 ➝ $350.00	+13.82%
9/15/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$311.00	+20.67%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$350.00 ➝ $355.00	+8.95%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:59 AM ET.

Should I Buy West Pharmaceutical Services Stock? WST Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 8, 2026. Please send any questions or comments about these West Pharmaceutical Services pros and cons to contact@marketbeat.com.

West Pharmaceutical Services
Bull Case

Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

The current stock price is around $312.77, reflecting strong market interest and potential for growth.
Recent upgrades from multiple analysts, including Barclays and Morgan Stanley, indicate positive sentiment and confidence in the company's future performance.
West Pharmaceutical Services, Inc. has a solid market capitalization of approximately $22.10 billion, suggesting stability and a strong position in the industry.
The company has a low debt-to-equity ratio of 0.07, indicating a strong balance sheet and lower financial risk, which is attractive to investors.
With a significant portion of shares (93.90%) held by institutional investors, there is a level of confidence from large financial entities in the company's prospects.

West Pharmaceutical Services
Bear Case

Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons:

Insider selling activity, including significant sales by executives, may raise concerns about the company's future performance and insider confidence.
The stock has a relatively high P/E ratio of 41.81, which could indicate that it is overvalued compared to its earnings, making it a riskier investment.
Despite recent upgrades, the average target price from analysts is $331.91, suggesting limited upside potential from the current price.
Market volatility, as indicated by a beta of 1.18, suggests that the stock may experience larger price swings, which could be a concern for risk-averse investors.
Recent insider ownership is low at 0.60%, which may indicate a lack of alignment between management and shareholder interests.

WST Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for West Pharmaceutical Services is $340.09, with a high forecast of $400.00 and a low forecast of $295.00.

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 2 hold ratings, 10 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" WST shares.

According to analysts, West Pharmaceutical Services's stock has a predicted upside of 3.58% based on their 12-month stock forecasts.

Over the previous 90 days, West Pharmaceutical Services's stock had 4 upgrades and 1 downgrade by analysts.

West Pharmaceutical Services has been rated by research analysts at Barclays, Citigroup, Evercore, Morgan Stanley, Stephens, Weiss Ratings, Wolfe Research, and Zacks Research in the past 90 days.

Analysts like West Pharmaceutical Services more than other "medical" companies. The consensus rating for West Pharmaceutical Services is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how WST compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With West Pharmaceutical Services Recommendations

This page (NYSE:WST) was last updated on 6/13/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Stock Forecast & Price Target